It is timely to consider the utility and practicability of screening for malignant hyperthermia susceptibility using genomic testing. Here the authors pose a simple, but bold question: what would it take to end deaths from malignant hyperthermia? The authors review recent advances and propose a scientific and clinical pathway toward this audacious goal to provoke discussion in the field.
Genomic Screening for Malignant Hyperthermia Susceptibility
Michael J. Avram, Ph.D., served as Handling Editor for this article.
Submitted for publication May 19, 2020. Accepted for publication August 11, 2020. Published online first on September 8, 2020.
- Views Icon Views
- Share Icon Share
- Search Site
Leslie G. Biesecker, Robert T. Dirksen, Thierry Girard, Philip M. Hopkins, Sheila Riazi, Henry Rosenberg, Kathryn Stowell, James Weber; Genomic Screening for Malignant Hyperthermia Susceptibility. Anesthesiology 2020; 133:1277–1282 doi: https://doi.org/10.1097/ALN.0000000000003547
Download citation file: